SCHEMBL6905265

SCHEMBL6905265

CC=C(c1ccccc1)C(c1ccccc1)c1ccc(C=CC(=O)NO)cc1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 11/20 0.58
HDAC2 Q92769 10/20 0.58
HDAC3 O15379 10/20 0.58
HDAC8 Q9BY41 9/20 0.58
HDAC6 Q9UBN7 8/20 0.58
HDAC4 P56524 7/20 0.58
HDAC10 Q969S8 7/20 0.58
HDAC7 Q8WUI4 6/20 0.58
HDAC11 Q96DB2 6/20 0.58
HDAC9 Q9UKV0 6/20 0.58
HDAC5 Q9UQL6 6/20 0.58
LMNA P02545 2/20 0.50
TDP1 Q9NUW8 1/20 0.49
EGFR P00533 1/20 0.46
PKM P14618 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7209286 0.87 KDM4E (0.55) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6904774 0.87 TDP1 (0.45) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6904753 0.86 TDP1 (0.44) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6898723 0.85 HDAC1 (0.48) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6898018 0.81 HDAC3 (0.45) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6901597 0.81 HDAC1 (0.48) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6905067 0.81 HDAC1 (0.41) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6900931 0.81 HDAC3 (0.45) HDAC1HDAC2HDAC3HDAC8HDAC6
SCHEMBL6903079 0.81 LMNA (0.50) LMNATDP1EGFRPKMHTT
SCHEMBL6903751 0.81 EGFR (0.40) HDAC1HDAC2HDAC3HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417169-A2 SELECTIVE ESTROGEN RECEPTOR MODULATORS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP claimed
WO-2003016270-A2 SELECTIVE ESTROGEN RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-02-27 WO claimed
EP-1417169-A2 SELECTIVE ESTROGEN RECEPTOR MODULATORS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003016270-A2 SELECTIVE ESTROGEN RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-02-27 WO disclosed